Looking for non-dilutive funding through the SBIR/STTR program?  Want expert personalized assistance?

The SBIR/STTR Assistance Program is a comprehensive program to increase participation by Washington state life science ventures. Its objective is to make writing and submitting an SBIR grant proposal easy and effective.  We are pleased to have assistance provided by experts such as Lisa Kurek from BBCetc and Robert Finney, who have extensive experience teaching the art of writing and winning SBIR/STTR grants.


Considering submitting an SBIR Application?  Recently received a Phase I award?

Join us for our next SBIR Workshop:


  • Current information on SBIR/STTR programs
  • How to approach each section of your proposal
  • Planning your commercialization strategy (the earlier the better)
  • Phase II proposal preparation
  • Common problems and pitfalls and how to avoid them


  • Planning on submitting an SBIR/STTR proposal in the next 12 months?
  • Have you recently received a Phase I Award? Planning a fast-track application?
  • Supporting SBIR/STTR applicants?
  • From an academic institution interested in working with SBIR/STTR applicants as subcontractors and supporting personnel?


Meet with NCI SBIR in Seattle, WA!

September 13, 2018
1:00 PM – 5 PM (individual time slots will be assigned)
Life Science Washington Institute
1551 Eastlake Ave E, Suite 300.
Seattle, WA 98102

Are you a small business in Washington looking for funding to advance your cancer research?  If so, then join NCI SBIR Program Director Dr. Ming Zhao at Life Science Washington Institute on Thursday, September 13 for one-on-one meetings with Dr. Zhao!

The one-on-one meetings will go from 1 PM to 5 PM. If you would like to sign up for a meeting with Dr. Zhao, please send your name, company name and a brief executive summary (or Specific Aims page if you are intend to apply Jan 5) to ingrid@lswinstitute.org  by September 5, 2018.

Ming Zhao, PhD, Program Director, SBIR Development Center, National Cancer Institute

Ming Zhao, Ph.D., is a Program Director in the SBIR Development Center at the National Cancer Institute.  In this role, Dr. Zhao develops and manages SBIR/STTR programs and contracts focused on cancer therapeutics, molecular diagnostics and medical imaging.  Prior to his appointment at NCI in 2009, he worked in industry including GE and Pfizer for over ten years.





Funding for this program is provided by: